Over 2 years (FY 2024 to FY 2026), Preferred Stock, Shares Outstanding shows a downward trend with a -100.0% CAGR.
An increase indicates the issuance of new preferred equity, while a decrease signals share repurchases or conversions into common stock.
This metric quantifies the total number of preferred stock shares currently held by all shareholders, excluding treasury...
Most large-cap pharmaceutical companies have simplified capital structures, so this is often zero or very low compared to common share counts.
other_preferred_stock_shares_outstanding| Q2 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $4.60M | $4.60M | $4.60M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +0.0% | -0.0% | -100.0% | — | — | — | — | — |
| YoY Change | — | — | -0.0% | — | -100.0% | — | -100.0% | — | — |